Table 3. Multivariate analysis of clinicopathological variables for the overall survival of the patients with ovarian carcinomas.
| Clinicopathological parameters | Overall survival | Relapse-free survival | ||
|---|---|---|---|---|
| Relative risk (95%CI) | P value | Relative risk (95%CI) | P value | |
| Age (≥56 y) | 1.949(0.954–3.982) | 0.067 | 1.716(0.949–3.102) | 0.074 |
| Pathological subtypes | 1.063(0.428–2.641) | 0.895 | 0.882(0.415–1.874) | 0.744 |
| FIGO staging(III-IVI) | 2.671(1.004–7.105) | 0.049 | 2.071(0.958–4.479) | 0.064 |
| Differentiation degree (poorly) | 1.579(0.762–3.269) | 0.219 | 1.082(0.602–1.945) | 0.791 |
| EMMPRIN protein expression (+~+++) | 1.542(0.763–3.232) | 0.251 | 1.625(0.882–2.993) | 0.120 |
| Remanant foci size (≥1 cm) | 1.931(0.862–4.512) | 0.129 | 1.431(0.717–2.857) | 0.309 |
| Serum CA125 level (≥500) | 0.976(0.494–1.928) | 0.944 | 1.147(0.648–2.033) | 0.638 |
Abbreviation: CI, confidence interval.